News & Analysis on Clinical Trial Services & Contract Research And Development
Dispatches from InformEx
When it comes to forging solid relationships between CMOs (contract manufacturing organizations) and drug developers, one thing is clear: deviations will occur.
Sanofi will invest in biologics and vaccine manufacturing capacity in 2015 to sustain product launches and ease constraints that impacted its Sanofi Pasteur division in the past few years.
Bankrupt cell therapy firm Dendreon has attracted more suitors according to stalking horse bidder Valeant, which upped its offer for the Provenge (sipuleucel-T) developer to $400m this week.
CRO consolidation continues with Rockville, MD-based Accelovance expanding its footprint into Europe with the acquisition of Cambridge, UK-based Altair Clinical.